Literature DB >> 6116755

Actions of dopamine and apomorphine on the vasoconstrictor responses of perfused mesenteric arteries of mouse, rat and rabbit.

N Anwar, D F Mason.   

Abstract

Dopamine (10(-7)--10(-6) M) and apomorphine (5 x 10(-7)--5 x 10(-6) M) inhibited the vasoconstrictor responses of the perfused mesenteric artery preparations of rat, rabbit and mouse to adrenergic nerve stimulation but did not affect responses to added noradrenaline. The inhibitory effects of both dopamine and apomorphine were prevented by haloperidol (3 x 10(-7) M) but not by yohimbine (3 x 10(-8) M) in rat and rabbit mesenteric artery preparations. In contrast, yohimbine (3 x 10(-8) M), but not haloperidol, antagonized the inhibitory effect of dopamine and apomorphine in mouse mesenteric artery preparations. In higher concentrations, dopamine (10(-6)--10(-4) M) produced a direct vascoconstrictor effect, which involved post-junctional alpha-adrenoceptors in all three species. However, in preparations contracted with 10(-7) M 5-hydroxytryptamine and in the presence of phentolamine (3 x 10(-7) M) and propranolol (10(-6) M), dopamine (10(-6)--10(-4) M) produced a direct relaxant effect in rabbit mesenteric artery preparations but not in those of rat and mouse. It is suggested that inhibition of neurogenic vasoconstrictor responses, by dopamine and apomorphine, may be mediated through a specific prejunctional inhibitory dopamine receptor in the mesenteric artery of rat and rabbit whereas in the mouse they involve activation of alpha-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116755     DOI: 10.1111/j.2042-7158.1981.tb13738.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  Inhibition of noradrenergic neurotransmission by apomorphine and pergolide in the in situ autoperfused rat renal and superior mesenteric vascular beds.

Authors:  A G Dupont; R A Lefebvre; M G Bogaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

2.  Presynaptic dopamine DA2-receptors in rabbit jejunal arteries. An electrophysiological study.

Authors:  W Nörenberg; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

3.  Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.

Authors:  W D Kerns; E Arena; D G Morgan
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

4.  Blood flow redistribution by dopamine in the feline gastrointestinal tract.

Authors:  R Kullmann; W R Breull; K Wassermann; A Konopatzki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

5.  Effects in vitro and in vivo by apomorphine in the rat corpus cavernosum.

Authors:  Kenshi Matsumoto; Masaki Yoshida; Karl-Erik Andersson; Petter Hedlund
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

6.  Dopamine inhibits prostaglandin F2 alpha-induced depolarization of rabbit jejunal arteries via activation of DA1-receptors.

Authors:  P Illes; W Nörenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

7.  Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries.

Authors:  Shinji Eguchi; Satoko Tezuka; Narumi Hobara; Shinji Akiyama; Yuji Kurosaki; Hiromu Kawasaki
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

8.  Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle.

Authors:  G M Drew; A Hilditch
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

9.  Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator.

Authors:  E M Yuhas; D G Morgan; E Arena; R P Kupp; L Z Saunders; H B Lewis
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.